In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Detecting toxic forms of tau before they weave into dense thickets of tangles could pave the way for earlier diagnosis and ...

As part of the funding, Latent Labs aims to leverage generative artificial intelligence to computationally create novel ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...